Kiran Vij.jpg

Kiran R. Vij, MD

Assistant Professor
Department of Medicine
Oncology Division
Bone Marrow Transplantation & Leukemia
Department of Pathology & Immunology

Clinical Interests

  • Hematopathology


  • 314-286-2354 (tel)
  • 314-362-7086 (fax)
  • 11th Floor Mid-Campus Center (office)
  • Division of Oncology
    Campus Box 8007
    Washington University Medical School
    660 South Euclid Avenue
    St. Louis, MO 63110


I hold a joint appointment in both the Division of Medical Oncology (Department of Medicine) and Division of Surgical Pathology (Department of Pathology/Immunology). Having fellowship training in hematopathology, clinical cytogenetics and surgical pathology, I have service commitments in hematopathology and gynaecologic pathology.

I oversee training of pathology residents and heme-path and surgical pathology fellows in training. I am also responsible for a didactic curriculum and providing basic training in hematopathology for clinical fellows and residents in medical oncology and hematology.

I work closely with clinicians and basic science researchers in Medical Oncology to further translational research projects in malignant hematology utilizing my skills in hematopathology and cytogenetics. These include serving as site pathologist for the multi-institutional Lymphoma Epidemiology of Outcomes (LEO) cohort study to support a broad research agenda aimed at identifying novel, clinical, epidemiologic, host genetic, tumor, and treatment factors that significantly influence NHL prognosis and survivorship. I am a co-investigator on the Specialized Program Of Research Excellence (SPORE) in Leukemia on studies that test novel approaches to develop biomarkers with a long term goal to treat patients with acute myeloid leukemia, acute lymphoid leukemia, and myelodysplastic syndromes.

I serve as the pathologist for several multicenter clinical trials studying the pathologic and clinical efficacy of neoadjuvant therapies in breast cancer and also in basic science studies involving murine models of graft versus host disease (GVHD).